BRIVIACT Trademark

Trademark Overview

On Wednesday, December 21, 2011, a trademark application was filed for BRIVIACT with the United States Patent and Trademark Office. The USPTO has given the BRIVIACT trademark a serial number of 79111360. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, March 18, 2023. This trademark is owned by UCB PHARMA S.A.. The BRIVIACT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of central nervous system diseases
briviact

General Information

Serial Number79111360
Word MarkBRIVIACT
Filing DateWednesday, December 21, 2011
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, March 18, 2023
Registration Number4228485
Registration DateTuesday, October 23, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 7, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of central nervous system diseases
Translation of Words in MarkThe wording "BRIVIACT" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 25, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB BIOPHARMA SRL
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressBruxelles B-1070
BE
Party NameUCB PHARMA S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBRUXELLES 1070
BE
Party NameUCB PHARMA S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBRUXELLES 1070
BE
Party NameUCB PHARMA S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBRUXELLES 1070
BE

Trademark Events

Event DateEvent Description
Saturday, March 18, 2023NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, March 18, 2023REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Saturday, March 11, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 12, 2022TEAS SECTION 71 & 15 RECEIVED
Wednesday, September 7, 2022CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, January 7, 2022INTERNATIONAL REGISTRATION RENEWED
Saturday, October 23, 2021COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, August 14, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, April 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, February 3, 2018NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, February 3, 2018REGISTERED-SEC.71 ACCEPTED
Saturday, February 3, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 10, 2018TEAS SECTION 71 RECEIVED
Monday, October 23, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, November 26, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, September 4, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 4, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 26, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 29, 2013FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, January 29, 2013FINAL DISPOSITION PROCESSED
Wednesday, January 23, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 23, 2012REGISTERED-PRINCIPAL REGISTER
Sunday, September 23, 2012NOTIFICATION PROCESSED BY IB
Wednesday, September 19, 2012ASSIGNED TO EXAMINER
Tuesday, August 7, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 18, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 18, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 18, 2012NOTICE OF PUBLICATION
Friday, June 29, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 14, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 14, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 7, 2012ASSIGNED TO LIE
Tuesday, May 29, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 29, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 29, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 19, 2012REFUSAL PROCESSED BY IB
Tuesday, May 1, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 1, 2012REFUSAL PROCESSED BY MPU
Tuesday, May 1, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 1, 2012APPLICATION FILING RECEIPT MAILED
Monday, April 30, 2012NON-FINAL ACTION WRITTEN
Wednesday, April 25, 2012ASSIGNED TO EXAMINER
Wednesday, April 25, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 23, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, April 21, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

briviact nervous system diseases central treatment preparations substances pharmaceutical